Clinical Trials in Phoenix

Showing 1001-1020 of 16,646 trials

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

NCT03726658

The purpose of this study is to evaluate the efficacy and safety of AGN-241751 in participants with Major Depressive Disorder

Major Depressive Disorder

Syndeio Biosciences, Inc226 participantsStarted Nov 2018

Phoenix, Arizona, United States • Garden Grove, California, United States • Atlanta, Georgia, United States +2 more locations

SUSPENDEDPhase 3< 1 mile

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

NCT03150693

This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.

B Acute Lymphoblastic Leukemia

Alliance for Clinical Trials in Oncology310 participantsStarted Sep 2017

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +457 more locations

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Find Trials by Condition in Phoenix

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection

Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention